Cite
Providing medication for opioid use disorder and HIV pre-exposure prophylaxis at syringe services programs via telemedicine: a pilot study.
MLA
McKellar, Mehri S., et al. “Providing Medication for Opioid Use Disorder and HIV Pre-Exposure Prophylaxis at Syringe Services Programs via Telemedicine: A Pilot Study.” Harm Reduction Journal, vol. 21, no. 1, Mar. 2024, pp. 1–12. EBSCOhost, https://doi.org/10.1186/s12954-024-00983-2.
APA
McKellar, M. S., Des Marais, A. C., Chen, H., Choi, Y., Lilly, R., Ayers, D., Bennett, J., Kestner, L., Perry, B., Poley, S., Corneli, A., Meade, C. S., & Sachdeva, N. (2024). Providing medication for opioid use disorder and HIV pre-exposure prophylaxis at syringe services programs via telemedicine: a pilot study. Harm Reduction Journal, 21(1), 1–12. https://doi.org/10.1186/s12954-024-00983-2
Chicago
McKellar, Mehri S., Andrea C. Des Marais, Hillary Chen, Yujung Choi, Rebecca Lilly, Denae Ayers, Jesse Bennett, et al. 2024. “Providing Medication for Opioid Use Disorder and HIV Pre-Exposure Prophylaxis at Syringe Services Programs via Telemedicine: A Pilot Study.” Harm Reduction Journal 21 (1): 1–12. doi:10.1186/s12954-024-00983-2.